Skip to content

Opening book details…

About this Medicine article

The average Adjusted Symptom Score, a new primary efficacy end-point for specific allergen immunotherapy trials by J.-M. Grouin; E. Vicaut; S. Jean-Alphonse; P. Demoly; U. Wahn; A. Didier; O. de Beaumont; A. Montagut; M. Le Gall; P. Devillier is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
J.-M. Grouin; E. Vicaut; S. Jean-Alphonse; P. Demoly; U. Wahn; A. Didier; O. de Beaumont; A. Montagut; M. Le Gall; P. Devillier
Publisher
John Wiley and Sons; Wiley (Blackwell Publishing); Blackwell Publishing Inc.; Wiley (ISSN 0954-7894)
Published
2011
Language
EN
Field
Medicine (Health Sciences)

More by J.-M. Grouin; E. Vicaut; S. Jean-Alphonse; P. Demoly; U. Wahn; A. Didier; O. de Beaumont; A. Montagut; M. Le Gall; P. Devillier

Browse all works by J.-M. Grouin; E. Vicaut; S. Jean-Alphonse; P. Demoly; U. Wahn; A. Didier; O. de Beaumont; A. Montagut; M. Le Gall; P. Devillier